Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/25 16:54 | 2/18/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Dananberg Jamie | CA | O | Chief Me | 1 | S | -16 | 2.96 | 0 | -6 | 33 | D | |||||||||||||||
2/20/25 16:52 | 2/18/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Artis Dean Richard | CA | O | EVP,CHIE | 1 | S | -16 | 2.97 | 0 | -6 | 84 | D | |||||||||||||||
2/20/25 16:51 | 2/18/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Yednock Ted | CA | O | EVP,CHIE | 2 | S | -30 | 2.92 | 0 | -10 | 70 | D | |||||||||||||||
2/20/25 16:49 | 2/18/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Overdorf Michael | CA | O | EVP,CHIE | 2 | S | -24 | 2.96 | 0 | -8 | 93 | D | |||||||||||||||
2/20/25 16:48 | 2/18/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | 2 | S | -26 | 2.93 | 0 | -9 | 85 | D | |||||||||||||||
2/18/25 16:30 | 2/13/25 | ANNX | Health | Drug | Pharmaceutical Preparations | Love Douglas | CA | DO | P,CEO | 1 | S | -15 | 2.95 | 0 | -5 | 352 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |